The NKG2D pathway in hepatitis B associated hepatocellular carcinoma in a highly endemic setting

Investigator from University of Navarra

Characterization of Key Epigenetic Targets in Hepatic Fibrosis and Hepatocellular Carcinoma Development. Generation of New Antifibrotic and Antitumoral Drugs.

Liver and intrahepatic bile ducts

Cheryl Winkler

Identification of Genetic Factors Associated with Infectious Diseases

Liver and intrahepatic bile ducts

Pathology

Frank Gonzalez

Xenobiotic metabolism, cancer chemoprevention and cancer biomarkers – Rockville

Liver and intrahepatic bile ducts

Pathology

Geoffrey D Girnun

Metabolic control of hepatocellular carcinoma by PGC1alpha

Liver and intrahepatic bile ducts

Pathology

Giorgio Trinchieri

Role of Inflammation, Innate Resistance, and Immunity in Carcinogenesis

Melanoma of skin Liver and intrahepatic bile ducts Colorectum

Sylvia Silver

The East Coast Aids and Cancer Specimen Resource

Trachea, bronchus and lung Non-Hodgkin lymphoma Liver and intrahepatic bile ducts Cervix uteri

Jacob Onu

Point-of-Delivery Prenatal Test Results through mHealth to Improve Birth Outcome

Liver and intrahepatic bile ducts

Corey Casper

Expanding Independent Research Capacity in HIV-Associated Malignancies in Uganda

Trachea, bronchus and lung Non-Hodgkin lymphoma Liver and intrahepatic bile ducts Kaposi sarcoma Colorectum Cervix uteri

Marshall Hicks

Pilot Program for Early Detection of Hepatocellular Carcinoma (HCC) in Underserved Communities: Development and Validation of Prognostic Markers

Liver and intrahepatic bile ducts